Aurobindo Pharma (NSE:AUROPHARMA) Other Operating Expense : ₹117,803 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Aurobindo Pharma Other Operating Expense?

Aurobindo Pharma's Other Operating Expense for the three months ended in Mar. 2024 was ₹30,983 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹117,803 Mil.

Aurobindo Pharma's quarterly Other Operating Expense increased from Sep. 2023 (₹29,282 Mil) to Dec. 2023 (₹29,426 Mil) and increased from Dec. 2023 (₹29,426 Mil) to Mar. 2024 (₹30,983 Mil).

Aurobindo Pharma's annual Other Operating Expense increased from Mar. 2022 (₹70,088 Mil) to Mar. 2023 (₹84,226 Mil) and increased from Mar. 2023 (₹84,226 Mil) to Mar. 2024 (₹117,803 Mil).

Aurobindo Pharma Other Operating Expense Historical Data

The historical data trend for Aurobindo Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurobindo Pharma Other Operating Expense Chart

Aurobindo Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

61,576.90

69,719.20

70,088.40

84,225.50

117,802.60

Aurobindo Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															27,910.90	28,111.20	29,282.40	29,426.20	30,982.80

Aurobindo Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹117,803 Mil.

Aurobindo Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Aurobindo Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurobindo Pharma (NSE:AUROPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (NSE:AUROPHARMA) » Definitions » Other Operating Expense

Traded in Other Exchanges

524804:India

Address

Plot No. 1, Survey No. 83/1, Galaxy, Floors: 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500 032

Website

https://www.aurobindo.com

Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Aurobindo Pharma (NSE:AUROPHARMA) Headlines

No Headlines